Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide. [electronic resource]
Producer: 20160303Description: 438-46 p. digitalISSN:- 1437-7772
- Administration, Oral
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Carcinoma, Squamous Cell -- diet therapy
- Ceramides -- biosynthesis
- Glucosylceramides -- administration & dosage
- Head and Neck Neoplasms -- diet therapy
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit -- biosynthesis
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Neovascularization, Pathologic -- diet therapy
- Vascular Endothelial Growth Factor A -- biosynthesis
- Vascular Endothelial Growth Factor Receptor-2 -- biosynthesis
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.